Cargando…
Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
Background: Kidney renal clear cell carcinoma (KIRC) is not sensitive to radiotherapy and chemotherapy, and only some KIRC patients can benefit from immunotherapy and targeted therapy. Cuproptosis is a new mechanism of cell death, which is closely related to tumor progression, prognosis and immunity...
Autores principales: | Yao, Yimin, Chen, Haixin, Lou, Minjun, Chen, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900009/ https://www.ncbi.nlm.nih.gov/pubmed/36755576 http://dx.doi.org/10.3389/fgene.2023.1071694 |
Ejemplares similares
-
Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022) -
A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Kenan, et al.
Publicado: (2022) -
Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma
por: Zeng, Song, et al.
Publicado: (2022) -
Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2022) -
Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2022)